Janice C Parker

Title: Janice C Parker: Innovator in Diabetes Treatment

Introduction

Janice C Parker is a prominent inventor based in Ledyard, CT (US). She has made significant contributions to the field of diabetes treatment through her innovative patents. With a total of 2 patents, her work focuses on developing new therapeutic agents for managing diabetes and related conditions.

Latest Patents

Janice's latest patents include "Fluorinated cyclic amides as dipeptidyl peptidase IV inhibitors." This invention relates to new therapeutically active and selective inhibitors of the enzyme dipeptidyl peptidase-IV. The pharmaceutical compositions derived from these compounds are aimed at treating various diseases associated with DPP-IV processing, such as Type 2 diabetes mellitus, hyperglycemia, and metabolic syndrome. Another notable patent is the "Synergistic effect of a sulfonylurea and/or non-sulfonylurea K+ATP channel blocker, and a phosphodiesterase 3 type inhibitor." This invention provides methods for treating non-insulin dependent diabetes mellitus and related conditions through the administration of specific pharmaceutical compositions.

Career Highlights

Janice C Parker is currently associated with Pfizer Corporation, where she continues to advance her research in diabetes treatment. Her work has been instrumental in developing innovative solutions that address critical health issues related to diabetes.

Collaborations

Janice has collaborated with notable colleagues, including Bernard Hulin and David A Fryburg, to further enhance her research and development efforts in the pharmaceutical field.

Conclusion

Janice C Parker's contributions to diabetes treatment through her innovative patents highlight her role as a leading inventor in the healthcare industry. Her work continues to impact the lives of many individuals affected by diabetes and related conditions.